c-fos-induced osteosarcoma formation in transgenic mice: cooperativity with c-jun and the role of endogenous c-fos - PubMed
- ️Sun Jan 01 1995
. 1995 Dec 15;55(24):6244-51.
Affiliations
- PMID: 8521421
c-fos-induced osteosarcoma formation in transgenic mice: cooperativity with c-jun and the role of endogenous c-fos
Z Q Wang et al. Cancer Res. 1995.
Abstract
Transgenic mice overexpressing the c-fos proto-oncogene in bone develop osteosarcomas, whereas mice overexpressing c-Jun are normal. In this study, we investigated whether Fos and Jun would cooperate in vivo and whether the threshold levels of Fos are important in osteosarcoma formation. Fos-Jun double-transgenic mice develop osteosarcomas at a higher frequency than single-Fos transgenic mice with no differences in the time of onset of tumor formation. Histological and histochemical analyses indicated that Fos-Jun tumors contained greater quantities of neoplastic bone, were more remodeled, and contained a greater number of multinucleated osteoclast-like cells than tumors isolated from age-matched, single transgenic littermates. In contrast, overexpression of Fos in knockout mice that lack endogenous Fos resulted in a decrease in the number of tumor-bearing mice; osteosarcomas were almost absent in c-fos -/- mice, whereas tumor incidence was reduced to approximately 50% in c-fos +/- mice. Cell lines isolated from Fos-Jun transgenic tumors expressed high levels of both transgenes but significantly lower levels of the jun-related gene junB compared with cells expressing only a c-fos transgene. Osteoblastic marker genes were expressed at varying levels in different cell lines, but expression of interstitial collagenase (matrix metalloproteinase-1) was enhanced in cells derived from Fos-Jun tumors. These studies demonstrate that coexpression of a c-jun transgene can enhance Fos-induced oncogenesis in vivo and suggest that a critical level of Fos is necessary for osteosarcoma development.
Similar articles
-
Sunters A, McCluskey J, Grigoriadis AE. Sunters A, et al. Dev Genet. 1998;22(4):386-97. doi: 10.1002/(SICI)1520-6408(1998)22:4<386::AID-DVG8>3.0.CO;2-2. Dev Genet. 1998. PMID: 9664690
-
Tuckermann JP, Vallon R, Gack S, Grigoriadis AE, Porte D, Lutz A, Wagner EF, Schmidt J, Angel P. Tuckermann JP, et al. Differentiation. 2001 Dec;69(1):49-57. doi: 10.1046/j.1432-0436.2001.690105.x. Differentiation. 2001. PMID: 11776394
-
AP-1 in mouse development and tumorigenesis.
Jochum W, Passegué E, Wagner EF. Jochum W, et al. Oncogene. 2001 Apr 30;20(19):2401-12. doi: 10.1038/sj.onc.1204389. Oncogene. 2001. PMID: 11402336 Review.
-
AP-1 (Fos/Jun) transcription factors in hematopoietic differentiation and apoptosis.
Liebermann DA, Gregory B, Hoffman B. Liebermann DA, et al. Int J Oncol. 1998 Mar;12(3):685-700. doi: 10.3892/ijo.12.3.685. Int J Oncol. 1998. PMID: 9472112 Review.
Cited by
-
The generation and use of animal models of osteosarcoma in cancer research.
Pu F, Guo H, Shi D, Chen F, Peng Y, Huang X, Liu J, Zhang Z, Shao Z. Pu F, et al. Genes Dis. 2023 Mar 24;11(2):664-674. doi: 10.1016/j.gendis.2022.12.021. eCollection 2024 Mar. Genes Dis. 2023. PMID: 37692517 Free PMC article. Review.
-
FOXP1 drives osteosarcoma development by repressing P21 and RB transcription downstream of P53.
Li H, Han X, Yang S, Wang Y, Dong Y, Tang T. Li H, et al. Oncogene. 2021 Apr;40(15):2785-2802. doi: 10.1038/s41388-021-01742-4. Epub 2021 Mar 14. Oncogene. 2021. PMID: 33716296
-
Dai Z, Tang H, Pan Y, Chen J, Li Y, Zhu J. Dai Z, et al. FEBS Open Bio. 2018 Apr 24;8(5):860-867. doi: 10.1002/2211-5463.12428. eCollection 2018 May. FEBS Open Bio. 2018. PMID: 29744300 Free PMC article.
-
MicroRNAs and Potential Targets in Osteosarcoma: Review.
Sampson VB, Yoo S, Kumar A, Vetter NS, Kolb EA. Sampson VB, et al. Front Pediatr. 2015 Aug 24;3:69. doi: 10.3389/fped.2015.00069. eCollection 2015. Front Pediatr. 2015. PMID: 26380245 Free PMC article. Review.
-
Genetically engineered mouse models and human osteosarcoma.
Ng AJ, Mutsaers AJ, Baker EK, Walkley CR. Ng AJ, et al. Clin Sarcoma Res. 2012 Oct 4;2(1):19. doi: 10.1186/2045-3329-2-19. Clin Sarcoma Res. 2012. PMID: 23036272 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous